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Apoptosis(R)-goniothalamin (R-GNT) is a styryl lactone that exhibits antiproliferative property against several tumor cell
lines. (S)-goniothalamin (S-GNT) is the synthetic enantiomer of R-GNT, and their biological properties are poorly
understood. The aim of this study was to evaluate the antiproliferative mechanisms of (R)-goniothalamin and
(S)-goniothalamin in MCF-7 breast cancer cells and HB4a epithelial mammary cells. To determine the mecha-
nisms of cell growth inhibition, we analyzed the ability of R-GNT and S-GNT to induce DNA damage, cell cycle ar-
rest and apoptosis. Moreover, the gene expression of cell cycle components, including cyclin, CDKs and CKIs, as
well as of genes involved in apoptosis and the DNA damage response were evaluated. The natural enantiomer
R-GNT proved more effective in both cell lines than did the synthetic enantiomer S-GNT, inhibiting cell prolifer-
ation via cell cycle arrest and apoptosis induction, likely in response to DNA damage. The cell cycle inhibition
caused by R-GNT was mediated through the upregulation of CIP/KIP cyclin-kinase inhibitors and through the
downregulation of cyclins and CDKs. S-GNT, in turn, was able to cause G0/G1 cell cycle arrest and DNA damage
inMCF-7 cells and apoptosis induction only in HB4a cells. Therefore, goniothalamin presents potent antiprolifer-
ative activity to breast cancer cells MCF-7. However, exposure to goniothalamin brings some undesirable effects
to non-tumor cells HB4a, including genotoxicity and apoptosis induction.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Breast cancer is the second most common cancer among women
worldwide. Although breast cancer exhibits good prognosis, mortality
rates remain high. In developed countries, the average survival rate at
5 years is 85%, whereas the survival rate in developing countries is
approximately 60% (WHO, 2012). Of all breast cancer patients, approxi-
mately 20–30% developmetastatic disease and exhibit an average surviv-
al between 2 and 4 years depending of the subtype of the disease (Eroles
et al., 2012). Therefore, new therapeutic strategieswith fewer side effects,
greater selectivity and a more effective response are required.
Several natural compounds with potent cytotoxic effects have been
used as anticancer drugs. One such molecule obtained from natural
source with potent antiproliferative activity is goniothalamin (GNT), a
styryl lactone found in members of the family Annonaceae, in the
Goniothalamus sp. (Wiart, 2007). The R conﬁguration (Right) is acceptedia Geral — CCB, Universidade
x 6001, Londrina, Paraná CEP:
ebon).as the absolute conﬁguration of this molecule in its natural form. (S)-
goniothalamin is the synthetic formof thismolecule (Fatima et al., 2006).
Among all of the bioactive properties of goniothalamin that have
been described, one of the most notable is its anti-proliferative activity
against various tumor cell lines, including breast cancer (Alabsi et al.,
2012; Chen et al., 2005; de Fatima et al., 2005; Wattanapiromsakul
et al., 2005), liver cancer (Al-Qubaisi et al., 2011; Tian et al., 2006), leu-
kemic cells (Inayat-Hussain et al., 1999; Inayat-Hussain et al., 2009;
Petsophonsakul et al., 2013; Rajab et al., 2005), colon cancer (Alabsi
et al., 2012; de Fatima et al., 2005; Wattanapiromsakul et al., 2005),
lung cancer (de Fatima et al., 2005; Semprebon et al., 2014;
Wattanapiromsakul et al., 2005), kidney cancer (de Fatima et al.,
2008; Wattanapiromsakul et al., 2005), ovarian and prostate cancer
(de Fatima et al., 2005). Furthermore, the synthetic enantiomer, (S)-
goniothalamin, also exhibits antiproliferative potential (de Fatima
et al., 2008; Fatima et al., 2006; Semprebon et al., 2014), but its mecha-
nism of action remains poorly understood. (R)-goniothalamin (R-GNT)
and (S)-goniothalamin (S-GNT) reportedly exhibit antitumor activity in
Ehrlich solid tumors without evidence of toxicity or weight loss in the
experimental animals (Vendramini-Costa et al., 2010). Several reports
suggest that induction of the intrinsic apoptosis pathway is the primary
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tivity in vitro (Alabsi et al., 2013; Barcelos et al., 2014; Kuo et al.,
2011; Petsophonsakul et al., 2013). However, little is known about its
effects on the cell cycle.
The cell cycle machinery promotes the progression of the cell from a
quiescent state (G0) to a proliferative state while ensuring genomic ﬁdel-
ity. The cyclin-dependent kinases (CDKs) associate with cyclins to drive
the progression of the cell through the cell cycle. CDKs 4, 6, 2 and 1 phos-
phorylate proteins responsible for cell cycle events. The cyclic changes in
the activities of these complexes are regulated by cyclins (D, E, A and B).
Mitogenic stimuli cause the accumulation of cyclin D1. The complex of
this cyclin with CDK4/6 phosphorylates the Rb protein. Rb phosphoryla-
tion causes its dissociation of E2F, a transcriptional factor that regulates
the expression of genes that encode components of subsequent cell
cycle events, such as cyclins E, A and B1 and CDK1, among others. The
next cyclin to be induced is cyclin E, which associates with CDK2 to pro-
mote the G1–S transition. The cyclin A/CDK2 complex is required for
the entry and completion of S phase, and cyclin A associates with CDK1
promote entry into M phase. Mitosis, in turn, is regulated by the cyclin
B/CDK1 complex (Malumbres and Barbacid, 2005). Cyclin-kinase inhibi-
tors (CKIs) can counteract CDK activity. The CIP/KIP family of CKIs in-
cludes p21, p27 and p57 (Romanov et al., 2012). CDKN1A is a
transcriptional target of p53 that encodes the p21Kip1 protein (Gartel
and Tyner, 1999; Macleod et al., 1995). This protein can inhibit the cell
cycle progression at G1, S (Besson et al., 2008) and G2/M phases (Lee
et al., 2009).
Themalignant phenotype results from themanifestation of essential
alterations in cell physiology that allow cancer cells survive, proliferate
and spread, such as sustained proliferative signaling, evasion of growth
suppressors and resistance of cell death, among others (Hanahan and
Weinberg, 2011). Genetic alterations in regulators of CDKs such as
cyclins and CKIs, or in its substrates such as the Rb protein are common
in human cancer (Malumbres and Barbacid, 2005). Therefore, com-
poundswith the ability tomodulate the cell cyclemachinery and induce
cell cycle arrest and apoptosis can be good targets for cancer treatment.
In this context, the aim of this study was evaluate the antiproliferative
mechanisms of (R)-goniothalamin and (S)-goniothalamin in breast
cancer MCF-7 cells and epithelial mammary HB4a cells, comparing
their effects in tumoral and non-tumoral cells. To determine the mech-
anisms of cell growth inhibition,we analyzed the ability of R-GNT and S-
GNT in induce DNA damage, cell cycle arrest and apoptosis. Moreover,
the gene expression of cell cycle components, such as cyclins, CDKs
and CKIs, as well as genes involved in the DNA damage response
(GADD45a) and apoptosis (CASP8 and CASP9) were evaluated. Our
study provides novel insight into the role of goniothalamin as a cell
cycle regulator in breast cells.2. Materials and methods
2.1. Chemicals
(R)-goniothalamin (R-GNT) and (S)-goniothalamin (S-GNT) (Fig. 1)
were synthesized in the Laboratório de Pesquisas deMoléculas BioativasFig. 1. Chemical structures of (R)-goniothalamin and (S)-goniothalamin.(LPMBA) of the Departamento de Química da Universidade Estadual de
Londrina (UEL) in collaboration with the Prof. Dr. Ângelo de Fátima of
Departamento de Química da Universidade Federal de Minas Gerais
(UFMG), as previously described (Fatima et al., 2006). The test substance
was solubilized in dimethylsulfoxide (DMSO) (Mallinckrodt Chemicals,
USA) at a concentration of 20.000 μM and stored at−20 °C. Upon use,
the solution was diluted in culture medium at experimental concentra-
tions. The composition of the GNT solutions was monitored through
the study by high resolution 1 H NMR (Bruker spectrometer, Model
Avance III) which showed that the test compounds had been intact at
above 97.5% purity. The DMSO concentration did not exceed 0.5% in cul-
ture. The control group received the amount of DMSO equivalent to the
treated group. The chemotherapeutic agent doxorubicin (Zodiac, Brazil)
was used at concentration of 1 μM as a positive control.
2.2. Cell culture
The human breast adenocarcinoma MCF-7 cell line was obtained
from Cell Bank of the Universidade Federal do Rio de Janeiro (BCRJ/
UFRJ), and the normal mammary epithelial HB4a cell line was kindly
provided by AC Camargo Hospital (SP). These cell lines were cultured
in Dulbecco's Modiﬁed Eagle Medium (DMEM) (Gibco®, Life Technolo-
gies, USA) supplemented with 10% fetal bovine serum (FBS, Gibco®)
and 1% penicillin/streptomycin (Gibco®) and maintained in a humidi-
ﬁed incubator containing 5% CO2 at 37 °C. The HB4a cell line was also
supplemented with 5 μg/ml of insulin (Gibco®) and 5 mg/ml of hydro-
cortisone. Under these conditions, the cell viability remained N90%.
2.3. Cell viability assay
The cell viability assay was based on the conversion of MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (Invitrogen
Life Technologies, USA) to formazan crystals bymitochondrial dehydro-
genase in living cells, as described byMosmann (1983)with somemod-
iﬁcations. Exponentially growing cells were seeded in 96-well plates at
a density of 5 × 103 cells/well in 100 μL of culture medium. After 24 h of
incubation, R-GNT and S-GNT (1, 10, 20, 30, 40, 50, 100 and 150 μM)
were added and remained in culture for 24 h and 48 h. After exposure,
the treatments were removed, and 100 μL of MTT reagent (0.5 mg/ml)
was added to each well and kept at 37 °C for 4 h to form formazan crys-
tals. The cell culture medium was aspirated, and 100 μL of DMSO was
added to dissolve the crystals. The absorbance was measured at
570 nm using a spectrophotometer (Thermo Plate). Assays were per-
formed in four replicates and three experiments. Cell viability (CV)
was expressed as a percentage of the negative control.
2.4. Real-time cell growth kinetics xCELLigence
The real-time growth kinetics of the cells was examined by an
impedance-based Real-Time Cell Analysis (RTCA) system xCELLigence
(Roche Diagnostic, Germany). This system monitors the cell biological
status through impedancemeasurements. Alterations in cellular biolog-
ical status, including the number of cells, cell viability, morphology and
adhesion, change the impedance values, which are expressed through
the Cell Index (CI), as produced by xCELLigence. Changes in impedance
are proportional to the number of cells in the well, the morphological
changes and adhesion. Thus, larger cell numbers are reﬂected in greater
impedance values (Xing et al., 2005). The RTCA station remained in a
humidiﬁed incubator containing 5% CO2 at 37 °C. Brieﬂy, 50 μL of medi-
umwas added to the 96-well E-plate, and background readingswere re-
corded. The cells were seeded at a density of 6250 MCF-7 cells/well or
3125 HB4a cells/well, according to data obtained in the titration exper-
iment. The E-plate containing the cells was incubated at room temper-
ature for 30 min and thereafter placed in the RTCA station. After 24 h,
when the cells were in a logarithmic growth phase, 100 μL R-GNT and
S-GNT (1, 10, 20, 30, 40, 50 and 100 μM)were added and kept in culture
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periment was designed according to the manufacturer's recommenda-
tions and was performed in triplicate. The cell growth curves were
normalized to the Cell Index (CI) at the last time point before treatment
addition using the RTCA software (Roche Diagnostic, Germany).
2.5. Cell cycle analysis
Brieﬂy, cells were seeded in 6-well plates at a density of 105 cells/
well. After 24 h of incubation, R-GNT and S-GNT (10 and 50 μM) were
added. After 3 h and 24h of exposure, cellswere trypsinized, resuspend-
ed in DMEM and centrifuged for 5 min. The cell suspension was resus-
pended in 100 μL HFS (50 mg/mL propidium iodide, 0.1% sodium
citrate, 0.1% Triton X-100) (Sigma Aldrich, USA) and incubated for
30min. After staining, theDNAcontent based on theﬂuorescence inten-
sity of PI was estimated by ﬂow cytometry (Guava easyCyte™,
Millipore, USA). The data were analyzed using a Guava software
(Millipore, USA). The percentages of cells in different phases of the
cycle (G1, S and G2/M) as well as the percentage of cells with
fragmented DNA (sub-G1 region) were estimated. For each sample ex-
amined, 5000 events were analyzed in three experiments.
2.6. Apoptosis assay
The apoptosis-inducing potential analyses of R and S-GNTwere per-
formed using an annexin V assay kit (Guava Nexin®, Millipore, USA).
The cells were seeded in 6-well plates at a density of 105 cells/well.
After 24 h of incubation, R-GNT and S-GNT (10 and 50 μM) were
added. After 3 h and 24 h of exposure, the cells were trypsinized, resus-
pended in DMEM and centrifuged for 5min. The cell suspensionwas re-
suspended in annexin V-PE (AV) and 7-amino-actinomycin-D (7-AAD)-
labeled and incubated for 30min. The data were collected and analyzed
using a Guava easyCyte™ ﬂow cytometer and Guava software
(Millipore, USA). Three cell populations were detected: viable cells
(AV−/7-AAD−), early apoptotic cells (AV+/7-AAD−), and late-stage
apoptotic and dead cells (AV+/7-AAD+). For each sample examined,
5000 events were analyzed in three experiments.
2.7. Hoechst 33342 staining assay
Hoechst 33342 is aDNA-speciﬁc dye. Hoechst 33342 stainingwas per-
formed to visualize morphologic characteristics of apoptosis, including
nuclear condensation and the formation of apoptotic bodies. The cells
were seeded in 6-well plates at a density of 105 cells/well. After 24 h of in-
cubation, R-GNT and S-GNT (10 and 50 μM) were added. After 24 h and
48 h of exposure, the cells were stained with Hoechst 33342 (5 μg/mL)
for 30 min at room temperature and observed immediately using a
FLoid® Cell Imaging Station (magniﬁcation of 460×, blue ﬁlter, 390/
40 nm excitation and 446/33 nm emission — Life Technologies, USA).
2.8. Single-cell gel electrophoresis assay (comet assay)
The alkaline comet assaywas performed to investigate the genotoxic
potential of goniothalamin according to the protocol of Tice et al. (2000)
with somemodiﬁcation. The cells were seeded in 6-well plates at a den-
sity of 105 cells/well. After 24 h of incubation, R-GNT and S-GNT (10 and
50 μM)were added. After 3 h of exposure, the cells were trypsinized, re-
suspended in DMEM and centrifuged for 5 min. Subsequently, 20 μL of
the cell suspensionwasmixedwith 120 μL of low-melting point agarose
(0.5%) and deposited onto a slide pregelatinized with agarose (normal
melting point, 1.5%), and then coveredwith a coverslip and left to solid-
ify. The slides were subject to 1 h lysis (2.5M sodium chloride, 100mM
EDTA, 10mM tris(hydroxymethyl)aminomethane (Tris), pH 10; 1% Tri-
ton X-100, and 10% DMSO). Alkaline denaturation for DNA unwinding
(20 min) and electrophoresis (300 mA, 25 V, 20 min) were performed
in a high pH buffer solution (200 mM EDTA, 10 N sodium hydroxide,and pH N 13). After electrophoresis, the slides were neutralized (0.4 M
Tris and pH 7.5), dehydrated with ethanol, stained with 100 μL of
0.002 mg/mL ethidium bromide solution and scored using a ﬂuores-
cence microscope equipped with a 420–490-nm UV excitation ﬁlter
and a 520-nm barrier ﬁlter (Leica). The comets were classiﬁed by visual
scoring into four categories based on the length of DNA migration
(Collins et al., 2008): class 0, undamaged cells and nucleoids without
tails; class 1, cells with damage and a tail smaller than the diameter of
the nucleoid; class 2, cells with damage and a tail twice the diameter
of the nucleoid; and class 3, cells with damage and a tail greater than
twice the diameter of the nucleoid. The damage index (DI) was calculat-
ed as follows: DI = N1 + (2 × N2) + (3 × N3), where N1, N2, and N3
represent the numbers of cells of damage levels 1, 2, and 3, respectively.
For each sample examined, 100 cells were analyzed in three experi-
ments. The cell viability analysis was conducted using the trypan blue
stain exclusion method, and only treatments with an index greater
than 80% were considered.
2.9. RT-qPCR
Cells were seeded in 6-well plates at a density of 105 cells/well. After
24 h of incubation, R-GNT (50 μM) was added and remained in culture
for 12 h. After the treatment, total RNA was isolated using the RNeasy
mini kit (Qiagen, USA) according to the manufacturer's recommenda-
tions. The RNA integrity was tested by agarose gel (1%) electrophoresis,
and the concentration and purity (A260/A280) were quantiﬁed on a
NanoDrop® 2000 (Thermo Fisher Scientiﬁc, USA). Isolated RNA was
stored at −80 °C until processing. cDNA synthesis was performed
using reverse transcriptase M-MLV (Invitrogen Life Technologies,
USA) and total RNA using oligo (dT) primers (Invitrogen Life Technolo-
gies, USA) according to the protocol of the enzyme. Each RT-qPCR reac-
tion was performed in a ﬁnal volume of 11 μL containing 5 μL of cDNA,
5 μL of SsoAdvanced™ SYBR® Green Supermix (Bio-rad Laboratories,
USA) and 1 μL of oligonucleotides. Quantitative PCRmeasurement reac-
tions were performed using the real-time detection system CFX96
TOUCH™ (Bio-rad Laboratories, USA) and the following conditions:
50 °C for 2 min, 95 °C for 2:15 min, 60 °C for 15 s, and 72 °C for 30 s;
40 cycles. The melting point analysis was performed at the end of the
reaction at a temperature of 55 °C to 95 °C every 0.5 °C for 5 s. The rela-
tive expression of each target gene was calculated using the average
value of the CT between the target gene and the reference genes glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH) and ribosomal protein
L13a (RPL13A) (Table 1). The reference genes were selected according
to the stability of gene expression among groups.
2.10. Statistical analysis
Data are presented as averages ± standard deviations of the three
independent experiments. Differences were considered signiﬁcant for
P values less than 0.05. The cell viability, cell cycle, apoptosis and
comet assay data were analyzed by analysis of variance (ANOVA)
followed by Dunnett's post-hoc test. The IC50 values were calculated
by non-linear regression (variable slope). RT-qPCR data were normal-
ized and analyzed according to Pfafﬂ and Dempﬂe (2002) using REST
2009 software (Pair Wise Fixed Reallocation Randomisation Test©). To
ﬁlter out unreliable data and to identify genes with signiﬁcantly differ-
ent expression, a standard 2-fold change in expression was used as
the cut-off point. The real-time PCR efﬁciencies were estimated by
LinRegPCR software.
3. Results
3.1. GNT reduces viability and cell growth
The MTT and Real-Time Cell Analyzer (RTCA) assays revealed that
both R and S-GNT reduced the cell viability and growth of MCF-7 cells
Table 1
Sequences of primers used in RT-qPCR.
Symbol Oligonucleotide Ref. seq ID
CCNB1 Forward AGA GCA TCT AAG ATT GGA GAG Sigma
Reverse CCA TGT CAT AGT CCA ACA TAG
CCNB2 Forward ATT TTT ACA GGT TCA GCC AG Sigma
Reverse ATC TCC TCA TAC TTG GAA GC
CCND1 Forward GCC TCT AAG ATG AAG GAG AC Sigma
Reverse CCA TTT GCA GCA GCT C
CCNE1 Forward GAC TTA CAT GAA GTG CTA CTG Sigma
Reverse GAC GAG AAA TGA TAC AAG GC
CDK1 Forward ATG AGG TAG TAA CAC TCT GG Sigma
Reverse CCT ATA CTC CAA ATG TCA ACT G
CDK2 Forward GAG ACC TTA AAC CTC AGA ATC Sigma
Reverse TGG AAT AAT ATT TGC AGC CC
CDK4 Forward GAA CAT TCT GGT GAC AAG TG Sigma
Reverse CAA AGA TAC AGC CAA CAC TC
CDK6 Forward GGA TAT GAT GTT TCA GCT TCT C Sigma
Reverse TCT GGA AAC TAT AGA TGC GG
CDK7 Forward CTA GGA TGT ATG GTG TAG GTG Sigma
Reverse AAG GAA CCC TTA GAA GTA ACT C
CDKN1A Forward CAG CAT GAC AGA TTT CTA CC Sigma
Reverse CAG GGT ATG TAC ATG AGG AG
CDKN1B Forward AAC CGA CGA TTC TTC TAC TC Sigma
Reverse TGT TTA CGT TTG ACG TCT TC
CDKN1C Forward CAA GTC TGT TAA AAT GGT TCC Sigma
Reverse TTT TTG CAG CAT TTT TCG G
CASP9 Forward CTC TAC TTT CCC AGG TTT Sigma
Reverse TTT CAC CGA AAC AGC ATT
CASP8 Forward GCA AAA GCA CGG GAG AAA GT Castaneda and Rosin-Steiner (2006)
Reverse TGC ATC CAA GTG TGT TCC ATT C
GADD45a Forward TCA GCG CAC GAT CAC TGT C Constructed
Reverse CCA GCA GGC ACA ACA CCA C
GAPDH Forward GAA GGT GAA GGT CGG AGT C Sugaya et al. (2005) with modiﬁcations
Reverse GGA AGA TGG TGA TGG GAT TT
RPL13A Forward CCT GGA GGA GAA GAG GAA AGA GA Brandimarto (2009)
Reverse TTG AGG ACC TCT GTG TAT TTG TCA A
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theMTT assay and cell growth kinetics analysis revealed that the natural
enantiomer R-GNT is more effective in reducing the cell viability and
cell growth than the enantiomer S-GNT.
Assessment of HB4a andMCF-7 cell viability was performed byMTT
assay (Fig. 2). There was a signiﬁcant reduction in the cell viability of
HB4a cells at all tested concentrations of R-GNT after 24 h (Fig. 2A)
and 48 h (Fig. 2B). MCF-7 cells also exhibited reduced viability after
24 h (Fig. 2A) and 48 h (Fig. 2B) of exposure at all concentrations of R-
GNT tested, except at 1 μM. S-GNT reduced HB4a cell viability after ex-
posure at all concentrations, except at 1 and 30 μM after 24 h (Fig. 2C)
and 1 μMafter 48h (Fig. 2D).MCF-7 cells exhibited reduced cell viability
after 24 h of exposure at all concentrations of S-GNT (Fig. 2C). After 48 h,
1 and 10 μM of S-GNT did not reduce MCF-7 cell viability (Fig. 2D).
The half-maximal inhibitory concentration (IC50) deﬁned by the
MTT assay of R-GNT after 48 h was 11.7 μM (R2 N 0.9) for HB4a and
52.12 μM for MCF-7 (R2 N 0.9), and the IC50 of S-GNT was 50.86 μM
(R2 N 0.8) for HB4a and N100 μM for MCF-7 cells (R2 = 0.8). Therefore,
for subsequent experiments, R and S-GNT were used at concentrations
of 10 μM and 50 μM.
The assessment of real-time cell growth kinetics performed using
the xCELLigence Real Time Cell Analyzer (RTCA) equipment (Fig. 3) re-
vealed that the R-GNT (50 μM and 100 μM) caused a great reduction in
the cell index as early as 3 h after treatment of HB4a (Fig. 3A) andMCF-7
cells (Fig. 3D). The HB4a cells treated with R-GNT (1 μM) showed a cell
growth similar to the control group. Upon 10 μM, there was a reduction
in normalized cell index according to the concentration of R-GNT
(Fig. 3A). Also the S-GNT showed a decrease in cell growth compared
to the control group from the concentration of 20 μM (Fig. 3B). MCF-7
cells presented a dose-dependent cell growth inhibition when treated
with R-GNT from the concentration of 20 μM (Fig. 3D). Already onlythe highest concentration (100 μM) of S-GNT reduced the MCF-7 cell
growth (Fig. 3E). Consistent to the cell growth curves, the photomicro-
graphs showed that there was a reduction in cell density and morpho-
logical changes such as rounding and shrinkage of HB4a (R-GNT: 10
and 50 μM; S-GNT: 50 μM) and of MCF-7 cells (R-GNT: 50 μM)
(Fig. 3C and F).
3.2. Goniothalamin induces cell cycle arrest
To investigate the mechanisms bywhich goniothalamin inhibits cell
growth, cell cycle (G1, S, G2, and sub-G1) analysis by ﬂow cytometry
was performed after 3 and 24 h of treatment with R and S-GNT (10
and 50 μM).
There was a slight reduction in the number of HB4a cells in the G0/
G1 cell cycle phase (p b 0.05) and a small, though not signiﬁcant, in-
crease in the number of cells in the G2/M phase after 3 h of treatment
with R-GNT (10 and 50 μM) and S-GNT (50 μM) (Fig. 4A and B). After
24 h of treatment with 50 μM R-GNT, we observed an increase in the
G2/M phase cell population (control: 35.15%; 50 μM R-GNT: 48.30%)
(p b 0.001) and a decrease in the number of cells in the G0/G1 phase
(control: 46.56%; 50 μM R-GNT: 24.22%) (p b 0.001) (Fig. 4A and C).
The analysis of the cell cycle distribution of MCF-7 cells demon-
strates that after 3 h of treatment with R-GNT (10 μM) and S-GNT
(10 μM) there was a slight decrease in the number of cells in the G0/
G1 phase (p b 0.05) (Fig. 4D and E). After 24 h of treatment (Fig. 4D
and Fig. 4F), we observed a signiﬁcant increase in the number of MCF-
7 cells in the G0/G1 phase after treatment with R-GNT (10 μM) and S-
GNT (10 and 50 μM) (Control: 44.10%; 10 μM R-GNT: 59.24%; 10 μM
S-GNT: 54.51%; 50 μM of S-GNT: 57.63%) (p b 0001). This increase in
the G0/G1 phase cell population was accompanied by a reduction in
the number of S phase cells in the groups treated with 10 μM R-GNT
Fig. 2.Cell viability (%) of MCF-7 and HB4a breast cell lines after 24 and 48 h of incubationwith 1–150 μMof R-GNT and S-GNTmeasured using theMTT assay. (A) Cell viability (%)
after exposure to R-GNT for 24 h and (B) 48 h. (C) Cell viability (%) after exposure to S-GNT for 24 h and (D) 48 h. Results are presented as the mean ± SD of three independent
experiments. * p b 0.05, ** p b 0.01, *** p b 0.001 relative to control using ANOVA followed by Dunnett.
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1.67%; 50 S-GNT: 5.76). In the group treated with 10 μM S-GNT, the in-
crease in the G0/G1 cell population was accompanied by a decrease in
the number of G2/M cells (Control: 34.76%; 10 μM S-GNT: 25.85%)
(p b 0.001). In addition, we observed a slight but not signiﬁcant increase
in the population of cells in the G2/M phase after treatment with 50 μM
R-GNT (Control: 34.7%; 50 μMR-GNT: 40%) as well as a slight reduction
in cell population in the S phase (Control: 13%; 50 μM R-GNT: 9.8%).
These results suggest that the treatment of HB4a cells with 50 μMR-
GNT induced G2/M cell cycle arrest, whereas the treatment of MCF-7
cells with R-GNT (10 μM) and S-GNT (10 and 50 μM) induced cell
cycle arrest in the G0/G1 phase.
3.3. Goniothalamin induces apoptosis
To investigate themechanisms of goniothalamin cytotoxicity, the in-
duction of apoptotic cell death was measured by annexin V-7AAD assay
after 24 h of treatment with R- and S-GNT (10 and 50 μM) (Fig. 5). The
treatment of HB4a cells with R-GNT (10 and 50 μM) and S-GNT (50 μM)
caused a decrease in the number of viable cells (Control: 87.83%; 10 μM
R-GNT: 81.13%; 50 μM R-GNT: 62.70%; 50 μM S-GNT: 81.10%) (p b
0.001) and an increase in cells in the early stage of apoptosis (Control:
7.67%; 10 μM R-GNT: 11.90%; 50 μM R-GNT: 17.57%; 50 μM S-GNT:
12.23%) (p b 0.001). Moreover, treatment with R-GNT (50 μM) caused
an increase in the number of cells in the late stages of apoptosis (Con-
trol: 3.80%; 50 μM R-GNT: 19.30% — p b 0.001) (Fig. 5A and B).
The analysis of the MCF-7 cells demonstrates that there was a little
decrease in the number of cells in late apoptosis (Control: 8.10%;
50 μM S-GNT: 4.87%) (p b 0.01). Treatment with 50 μM R-GNT induced
a decrease in the number of viable cells (Control: 90.20%; 50 μM:
83.20%) (p b 0.001) and an increase in the number of cells in late-stage apoptosis (Control: 8.10%; 50 μM: 15.17%) (p b 0.001) (Fig. 5C
and D).
The total proportion of apoptotic cells labeledwith annexin V (AV+/
7-AAD+ and AV+/7-AAD−) after treatment with 50 μM R-GNT was
36.87% for HB4a cells and 16.34% for MCF-7 cells. The Hoechst 33342
staining showed that the most of the HB4a (Fig. 5A) cells and MCF-7
cells (Fig. 5C) in the control group exhibited normal staining of chroma-
tin and normal nuclear morphology, whereas there was an increase in
the number of cells that exhibited strong ﬂuorescence, chromatin con-
densation, and fragmented nuclei in the MCF-7 cells treated with R-
GNT (50 μM) and in HB4a cells treated with R-GNT and S-GNT (10
and 50 μM).
3.4. Goniothalamin induces DNA damage
DNA damage can result in cell cycle arrest and cell death by apopto-
sis. To investigate the potential of goniothalamin to induceDNAdamage
in HB4a and MCF-7 cells, a Comet Assay was performed after 3 h of
treatment with R-GNT and S-GNT (10 μM and 50 μM).). The analysis
of the damage index (DI) showed that treatment of HB4a cells with R-
GNT (50 μM) (p b 0.01) (Fig. 6A) and of MCF-7 cells with R-GNT
(10 μMand 50 μM) and S-GNT (10 μMand 50 μM) resulted in induction
of DNA damage (p b 0.01) (Fig. 6B). The S-GNT was not genotoxic to
HB4a cells.
3.5. (R)-goniothalamin changes the expression of cell cycle control genes
R-GNT dramatically changed the cell cycle dynamic and induced ap-
optosis in both mammary cell lines examined. Thus, to analyze the ef-
fects of R-GNT in the regulation of genes involved in the cell cycle and
apoptosis pathway, cells were treated with 50 μM R-GNT for 12 h,
255S.C. Semprebon et al. / Toxicology in Vitro 30 (2015) 250–263followed by measurement of mRNA levels by RT-qPCR. The analysis of
HB4a cells (Fig. 7A) revealed that the mRNA levels of cyclins (CCNB1:
5.2-fold-change and CCNB2: 5.2-fold-change) and CDKs (CDK1: 2.3-
fold-change and CDK4: 2.82-fold-change) were downregulated. The
mRNA levels of the cyclin-dependent kinase inhibitor CDKN1A wasFig. 3.Real-timemonitoring ofHB4a andMCF-7 cells obtained using the xCELLigence systemdem
50and100 μM). (A)Growth curves of HB4a cells exposed to R-GNTand (B) S-GNT. (C) Photomic
and 48h. (D)Growth curves ofMCF-7 cells exposed to R-GNT and (E) S-GNT. (F) Photomicrogra
48 h (460× magniﬁcation). The results are presented as the means of three replicates with staupregulated (14-fold-change). InMCF-7 cells (Fig. 7B), themRNA levels
of cyclins (CCND1: 2.79-fold-change; CCNB1: 4.5-fold-change, CCNB2:
6.7-fold-change) and CDKs (CDK1: 8.3-fold-change, CDK2: 4.3-fold-
change and CDK4: 2-fold-change) were downregulated, whereas the
levels of the cyclin-dependent kinase inhibitor CDKN1A (16.6-fold-onstrating thekinetics of cell growth after exposure to R-GNTandS-GNT (1, 10, 20, 30, 40,
rographofHB4a cells after treatmentwith R-GNT and S-GNT (10 μMand50 μM) for 3, 6, 24
ph ofMCF-7 cells after treatmentwith R-GNT and S-GNT (10 μMand50 μM) for 3, 6, 24 and
ndard error bars.
Fig. 3 (continued).
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the most responsive gene after treatment with R-GNT, with a greater
than sixteen- and fourteen-fold increase in expression in MCF-7 and
HB4a cells, respectively. The mRNA levels of genes that encode caspase
8 (CASP8) and caspase 9 (CASP9) were unchanged (Fig. 8).
The mRNA levels of GADD45awas investigated by RT-qPCR after 3 h
and 12 h of exposure to genotoxic concentrations of R-GNT (50 μM)
(Fig. 9). The mRNA levels of the GADD45a gene were upregulated after12 h of exposure to R-GNT in both cell lines (HB4a: 4.74-fold-change;
MCF-7: 9-fold-change).
4. Discussion
Evidence obtained from in vitro (Alabsi et al., 2012; de Fatima et al.,
2008) and in vivo experiments (Vendramini-Costa et al., 2010) indicates
that goniothalamin might have therapeutic potential for the treatment
257S.C. Semprebon et al. / Toxicology in Vitro 30 (2015) 250–263of cancer. In this study, we determined that goniothalamin exhibits
dose- and time-dependent antiproliferative activity against HB4a and
MCF-7 cells. Both cell viability and cell growth kinetic analysis revealed
that the natural enantiomer R-GNTwasmore effective than the synthet-
ic enantiomer S-GNT. The antiproliferative activity of goniothalamin
against the MCF-7 and HB4a cells appeared to be the result of cell
cycle arrest and the induction of cell death by apoptosis, probably in re-
sponse to the induction of DNA damage. This is the ﬁrst study thatFig. 4. Cell cycle analysis (G0/G1, S, G2/M and subG1) of HB4a and MCF-7 cells after exposure
(A) Representative histograms indicate the number of cells (vertical axis) vs. DNA content (h
50 μM). (B) HB4a cell cycle distribution after 3 h of exposure to R and S-GNT (10 μM and 50 μ
axis) vs. DNA content (horizontal axis) after 3 and 24 h of treatment of MCF-7 cells with R an
and S-GNT (10 μM and 50 μM) and (F) after 24 h. Results are presented as the mean ± SD o
using ANOVA followed by Dunnett.demonstrated the inﬂuence of GNT in the regulation of the expression
of genes involved in cell cycle control.
Among all of the bioactive properties described, the anti-
proliferative activity of goniothalamin against cancer cells is most nota-
ble. Moreover, some authors have suggested a possible selectivity of
goniothalamin against tumor cell lineswith limited activity against nor-
mal cells, which has attracted interest in this molecule in the last two
decades (Pihie et al., 1998; Tian et al., 2006; Wattanapiromsakul et al.,to R and S-GNT (10 μM and 50 μM) by ﬂow cytometry using propidium iodide labeling.
orizontal axis) after 3 and 24 h of treatment of HB4a cells with R and S-GNT (10 μM and
M) and (C) after 24 h. (D) Representative histograms depict the number of cells (vertical
d S-GNT (10 μM and 50 μM). (E) MCF-7 cell cycle distribution after 3 h of exposure to R
f three independent experiments. * p b 0.05, ** p b 0.01, *** p b 0.001 relative to control
Fig. 4 (continued).
258 S.C. Semprebon et al. / Toxicology in Vitro 30 (2015) 250–2632005). In the present study,we observed a potent cytotoxic and antipro-
liferative effect of goniothalamin against breast cell lines at low concen-
trations in a dose- and time-dependentmanner. However, there was no
selective cytotoxicity for MCF-7 tumor cells relative HB4a non-tumor
cells.
The analysis of real-time cell growth allows us to verify the effects of
a given compound at several points of time, permitting dynamic moni-
toring of the effects of a compound on cell growth (Abassi et al., 2009).
Cell growth inhibition after exposure to R-GNT began within the ﬁrst
3 h, demonstrating an early cellular response to treatment. In both the
MTT assay and RTCA analysis, the natural enantiomer R-GNT proved
more effective against both cell lines relative to the syntheticenantiomer S-GNT. Although both enantiomeric forms exhibit the
same chemical and physical properties, their biological activities differ
considerably, likely due to the speciﬁc interactions of enantiomers
with biological receptors (Tucker, 2000).
Cell index (CI) variations reﬂect alterations in cellular biological sta-
tus, including the number of cells, cell viability, morphology and adhe-
sion. The cell viability determined by MTT assay can be deﬁned as the
number of healthy cells; however, it is not possible to distinguish
whether the cells are actively dividing or are quiescent. Therefore, we
investigated the effects of GNT in the range close to the IC50 of R-GNT
values for HB4a (10 μM) and MCF-7 (50 μM) on the ability to induce
cell death by apoptosis and to cause cell cycle arrest. Consistent with
259S.C. Semprebon et al. / Toxicology in Vitro 30 (2015) 250–263the observation of a decrease in the cell index, we observed that
goniothalamin was able to induce DNA damage, cell cycle arrest and
apoptosis.
The cellular DNA damage response (DDR) detects DNA lesions and
initiates DNA damage checkpoints. DNA damage checkpoints occurFig. 5. Effects of R-GNT and S-GNT (10 μM and 50 μM) on apoptosis induction. The apoptosis a
mycin D (7-AAD), and the events were classiﬁed into three cell populations: viable cells (AV−
(AV+/7-AAD+). (A) Representative graphs of quantiﬁcation of annexinV (AV) and7-amino-ac
ingwithHoechst 33342 ofHB4a cells. (B) Percentage ofHB4a cells in early and late apoptosis aft
of quantiﬁcation of annexin V (AV) and 7-amino-actinomycin D (7-AAD) staining and photo
(D) Percentage of MCF-7 cells in early and late apoptosis after 24 h of treatment with R-GNT a
* p b 0.05, ** p b 0.01, *** p b 0.001 compared to control using ANOVA followed byDunnett. Arro
(magniﬁcation = 460×).throughout the cell cycle, and the cells may transiently arrest in the
G1/S or G2/M transitions or may permanently arrest (senescence) and
activate DNA repair mechanisms in response to genotoxic insults. If
the DNA damage is not amenable to repair, the cells may undergo
death by apoptosis (Cheung-Ong et al., 2013). R-GNTwas able to inducenalysis was performed by ﬂow cytometry using Annexin V-PE (AV) and 7-amino-actino-
/7-AAD−), early apoptotic cells (AV+/7-AAD−), and late stage apoptotic and dead cells
tinomycinD (7-AAD) staining andphotomicrographs showingmorphology and the stain-
er 24 h of treatmentwith R-GNT and S-GNT (10 μMand 50 μM). (C) Representative graphs
micrographs showing morphology and the staining with Hoechst 33342 of MCF-7 cells.
nd S-GNT (10 μM and 50 μM). Results are mean ± SD of three independent experiments.
w indicates cells with condensed chromatin and arrowhead indicates the apoptotic bodies
Fig. 5 (continued).
260 S.C. Semprebon et al. / Toxicology in Vitro 30 (2015) 250–263genotoxicity in HB4a and MCF-7 cells. S-GNT, in turn, was genotoxic
only for the tumor cell lineMCF-7. These results are consistentwith pre-
vious reports that attribute the cytotoxic effect of goniothalamin to its
genotoxicity (Inayat-Hussain et al., 2009; Kuo et al., 2011; Rajab et al.,
2005). In addition, the gene GADD45a, which is regulated in response
to DNA damage, was upregulated after R-GNT exposure. Accumulating
evidence suggests that the overexpression of the growth arrest and
DNA damage (Gadd) 45a gene (GADD45a) suppress cell proliferation
through cell cycle arrest and apoptosis induction (Tamura et al.,
2012). Numerous studies have found a correlation between the upreg-
ulation of GADD45a and G2/M cell cycle arrest (Jin et al., 2002; Li
et al., 2009; Wang et al., 1999). This response occurs because the
Gadd45α protein strongly inhibits the kinase activity of the complexCDK1/Cyclin B1, which is responsible for transitioning the G2 cell tomi-
tosis (Jin et al., 2000).
After DNA damage, p53 protein is activated and upregulates target
genes that control the cellular response, such asCDKN1A, a gene that en-
codes the p21 protein. Our gene expression analysis revealed that the
mRNA levels of CDKN1Aweremarkedly up-regulated after R-GNT treat-
ment in both cell lines. CDKN1C, which also belongs to the CIP/KIP
cyclin-kinase inhibitor family, was also up-regulated in MCF-7 cells
after treatment with R-GNT. It is well established that induction of the
p21 response associated with DNA damage causes cell cycle arrest in
the G1 and G2 phases (Abbas and Dutta, 2009).
R-GNT (50 μM) induced cell cycle arrest in the G2/M phase in HB4a
cells. InMCF-7 cells, we observedG1 arrestwhen the cellswere exposed
Fig. 6. Evaluation of the damage index (DI) after 3 h of exposure of HB4a andMCF-7 cells to R-GNT and S-GNT (10 μMand 50 μM)measured using the Comet Assay. (A)Damage Index (DI)
inHB4a and (B)MCF-7 cells. Data are presented as themean±SDof three independent experiments. * p b 0.05, ** p b 0.01, *** p b 0.001 relative to the control groupusingANOVA followed
by Dunnett.
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treatment of MCF-7 cells with a higher concentration of R-GNT
(50 μM) caused a slight increase in the population of cells in the G2/M
phase. Other authors has been attributed the antiproliferative activity
of goniothalamin to cell cycle arrest at the G0/G1 (Barcelos et al.,
2014), G2/M (Chen et al., 2005; Tian et al., 2006) and S phases (Alabsi
et al., 2012). Exposure of HepG2 cells and HepG2-R to GNT (15 μM)
caused G2/M cell cycle arrest and increased the sub-G1 population
(Tian et al., 2006). The treatment of MDA-MB-231 cells with GNT
(30 μM) also led to cell cycle arrest at the G2/M phase with a concomi-
tant reduction in G1 (Chen et al., 2005). On the other hand, Barcelos
et al. (2014) suggested that PANC-1 cells exposed to GNT exhibit G0/
G1 cell cycle arrest.
Analysis of the expression levels of cell cyclemachinery components
by RT-qPCR revealed the downregulation of some cyclins and CDKs. The
mRNA levels of CCND1 and CDK4 were downregulated in MCF-7 cells,
but only CDK4 was downregulated in non-tumoral HB4a cells. The
downregulation of CCND1, a gene that encodes cyclin D1, observed in
MCF-7 cells is consistent with a previous study reporting that the expo-
sure of PANC-1 cells to GNT led to a decrease in the cyclin D1 protein
levels and in the phosphorylation of Rb protein (Barcelos et al., 2014).
The overexpression of cyclin D1 is a feature of breast cancer, occurringFig. 7.RT-qPCR analysis of genes involved in cell cycle regulation. Graphs shown the relative gen
after 12 h of exposure to R-GNT 50 μM. The relative expression of each target gene was norma
ribosomal protein L13a (RPL13A). Data are expressed as fold changes relative to control group i
trol are indicated by * (REST 2009 software ®).in 50% of cases, and MCF-7 breast cancer cells express high levels of cy-
clin D1 (Zhou et al., 1997). Thus, cyclin D is partially responsible for the
excessive proliferation of cancer cells in many human cancers and is
therefore a good target for the development of anticancer drugs
(Musgrove et al., 2011). Moreover, the cyclin E/CDK2 complex is re-
quired for cells to transition from G1 to S. This complex contributes to
the maintenance of hyperphosphorylated Rb and the positive feedback
stimulating the accumulation of E2F. The association of CDK2 with cy-
clin A also contributes to DNA replication (Malumbres and Barbacid,
2009). Although there were no changes in the mRNA levels of cyclin
E1, the levels of CDK2 were drastically reduced in MCF-7 cells.
The G2–M cell cycle phase transition is regulated by CDK1 in associ-
ation with cyclins A, B1 and B2. These complexes phosphorylate cyto-
skeletal proteins and mitotic spindle components (Nigg, 2001). In
both cells, we observed the downregulation of genes that encode cyclins
B1 and B2 as well as CDK1. Therefore, the reduced expression of cyclin
D1 and CDK4 mRNA in addition to the downregulation of CDK2 in
MCF-7 cells, both positive regulators of the G1-S transition, could be re-
lated to G1 cell cycle arrest. However, R-GNT induced G0/G1 cell cycle
arrest in MCF-7 cells only at the lower tested concentration of R-GNT
(10 μM). On the other hand, the downregulation of CCNB1, CCNB2 and
CDK1 in both cell lines may contribute to the evident G2/M cell cyclee expression (fold-change) of cyclins, CDKs andCKIs genes in (A)HB4a and (B)MCF-7 cells
lized with the reference genes Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and
n three independent experiments (mean± SEM). Statistical differences compared to con-
Fig. 8. RT-qPCR analysis of genes involved apoptosis pathway. Graphs shown the relative gene expression (fold-change) of CASP9 and CASP8 in (A) HB4a and (B)MCF-7 cells after 12 h of
exposure to R-GNT 50 μM. The relative expression of each target genewas normalizedwith the reference genes glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Data are expressed
as fold changes relative to control group in three independent experiments (mean ± SEM). Statistical differences compared to Control are indicated by * (REST 2009 software ®).
262 S.C. Semprebon et al. / Toxicology in Vitro 30 (2015) 250–263arrest after R-GNT treatment in HB4a cells and to the slight increase in
the population of cells in the G2/M phase after treatment of MCF-7
cells with 50 μMR-GNT. This ﬁnding suggests that the relative contribu-
tion of G1 arrest or G2/M arrest may vary according to the cell line,
treatment time and dose. Moreover, the CDKN1A upregulation might
contribute to downregulation of cyclins and CDKs genes. Microarray-
based studies suggest that induction of p21 is correlated with the sup-
pression of genes involved in cell cycle progression, such as CDK1
(Chang et al., 2000), CCNB1, CCNB2 and CDK2 (Ferrandiz et al., 2012).
In addition to the cytostatic activity of R-GNT, we also observe cyto-
toxicity by inducing cell death by apoptosis in HB4a and MCF-7 cells.
MCF-7 cells exhibited greater resistance to cell death induced by
goniothalamin relative to HB4a cells. Consistent with our study, breast
cancer MDA-MB-231 cells exposed to GNT (30 μM) have been reported
to exhibit an increase in the population of apoptotic cells with mito-
chondrial efﬂux of cytochrome-c and activation of the effector
caspase-3 (Chen et al., 2005). The induction of cell death by apoptosis
is one of the most established mechanisms of action for GNT, and
other authors have reported its potential to induce apoptosis (Alabsi
et al., 2013; Barcelos et al., 2014; Kuo et al., 2011; Petsophonsakul
et al., 2013). Most studies report that apoptosis induced by GNT occurs
through by intrinsic pathway, with activation of initiator caspase-9
(Alabsi et al., 2013; Inayat-Hussain et al., 2003), decrease in mitochon-
drial membrane potential, and mitochondrial release of cytochrome-c
(Kuo et al., 2011) and of SMAC/DIABLO (Petsophonsakul et al., 2013).
Some reports also suggest that the extrinsic pathway participates in
GNT-induced apoptosis, as demonstrated by the activation of the initia-
tor caspase of the extrinsic pathway, caspase-8 (Kuo et al., 2011;
Petsophonsakul et al., 2013). The caspase initiator-2 (Chan et al.,Fig. 9. RT-qPCR analysis of Growth Arrest and DNA Damage (Gadd) 45a gene (GADD45a).
cells after 3 h and 12 h of exposure to R-GNT 50 μM. The relative expression of target gene w
(GAPDH). Data are expressed as fold changes relative to control group in three independe
cated by * (REST 2009 software ®).2010) and the caspases effector-3 and -7 have been activated by
goniothalamin exposure (Al-Qubaisi et al., 2013; Inayat-Hussain et al.,
1999). However, in this study, therewas no differential gene expression
of CASP8 and CASP9, the genes that are encoded to caspase-8 and to
caspase-9, respectively. S-GNT, unlike R-GNT, exhibited low cytotoxicity
and did not induce cell death by apoptosis in MCF-7 cells. There is a re-
port that this enantiomer induced cell death mainly by autophagy in
kidney 786-O cells (de Fatima et al., 2008). However, S-GNT at 50 μM
was able to induce apoptosis in HB4a cells.
5. Conclusion
In summary, in the current study, we observed the potent antiprolif-
erative activity of goniothalamin against breast cell lines in a dose- and
time-dependentmanner. Indeed, there was no selective cytotoxicity for
MCF-7 tumor cells relative to HB4a non-tumor cells. The natural enan-
tiomer R-GNT proved most effective for both cell lines relative to the
synthetic enantiomer S-GNT. R-GNT can inhibit cell proliferation via
cell cycle arrest and apoptosis induction, likely in response to DNA dam-
age and upregulation of GADD45a gene. R-GNT induced G0/G1 and G2/
M cell cycle arrest inMCF-7 cells, according to the concentration, as well
as G2/M cell cycle arrest in HB4a cells. The cell cycle inhibition induced
by R-GNTwasmediated by the upregulation of CIP/KIP cyclin-kinase in-
hibitors and by the downregulation of cyclins and CDKs. S-GNT, in turn,
was able to induce G0/G1 cell cycle arrest and DNA damage in MCF-7
cells and to induce apoptosis only in HB4a cells. Therefore,
goniothalamin presents potent antiproliferative activity to breast cancer
cell lineMCF-7 in a dose- and time-dependentmanner. However, expo-
sure to this goniothalamin brings some undesirable effects to non-Graphs shown the relative gene expression (fold-change in (A) HB4a and (B) MCF-7
as normalized with the reference genes Glyceraldehyde 3-phosphate dehydrogenase
nt experiments (mean ± SEM). Statistical differences compared to Control are indi-
263S.C. Semprebon et al. / Toxicology in Vitro 30 (2015) 250–263tumor cells HB4a, including genotoxicity and apoptosis induction, and
further studies are needed to clarify their potential toxic effects.
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